Actively Recruiting
A Pilot Randomized Controlled Trial Comparing Core Exercise, Aerobic Exercise, and Combined Exercise in Patients Undergoing Phase II Cardiac Rehabilitation
Led by National Taiwan University Hospital · Updated on 2025-11-24
60
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the impact of adding core muscle endurance training to cardiac rehabilitation (CR) for adults with stable myocardial infarction (MI) or heart failure (HF). This randomized trial aims to clarify the safety and feasibility of core training alongside standard aerobic CR and to compare their effects on fitness, core endurance, balance, symptoms, and quality of life. The study will help guide exercise prescriptions in Phase II CR for this population. Participants are randomly assigned to one of three groups: Pilates-based core endurance training twice weekly, standard aerobic training twice weekly using treadmill or cycle ergometer, or a combined program with one session of each per week. Each session lasts about 60 minutes, supervised with continuous safety monitoring, and the intervention period lasts eight weeks. During the study, participants undergo baseline and post-training assessments including peak oxygen uptake, six-minute walk distance, various core endurance and balance tests, hand grip strength, body composition, and symptom questionnaires. Researchers monitor safety continuously, and participants attend supervised sessions twice per week for eight weeks. The study duration includes initial testing, the training program, and follow-up assessments to evaluate changes in fitness and function.
CONDITIONS
Brief Title
A Pilot Randomized Controlled Trial Comparing Core Exercise, Aerobic Exercise, and Combined Exercise in Patients Undergoing Phase II Cardiac Rehabilitation.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Diagnosed with myocardial infarction or heart failure with stable condition
- Referred for participation in Phase II cardiac rehabilitation
- Able to attend training sessions twice a week regularly
You will not qualify if you...
- Cardiac surgery within the past three months
- Presence of pacemaker, defibrillator, or left ventricular assist device
- Cognitive impairment or dementia preventing understanding or following training
- Inability to complete cardiopulmonary exercise testing
- Pregnancy
- Contraindications to cardiac rehabilitation based on ACSM guidelines, including unstable angina, uncontrolled severe hypertension, orthostatic hypotension, severe aortic stenosis, uncontrolled arrhythmia, decompensated heart failure, third-degree atrioventricular block, acute pericarditis or myocarditis, aortic dissection, acute pulmonary embolism, or other acute medical conditions
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 8 weeks
Participants undergo an 8-week exercise training program consisting of either core exercise, aerobic exercise, or a combination of both, with sessions twice per week.
Two exercise sessions per week
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan
Actively Recruiting
Research Team
H
Hung-Jui Chuang, Dr.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here